These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9244182

  • 1. Effects of peroxovanadate and vanadate on insulin binding, degradation and sensitivity in rat adipocytes.
    Yu ZW, Posner BI, Smith U, Eriksson JW.
    Biochim Biophys Acta; 1996 Jan 10; 1310(1):103-9. PubMed ID: 9244182
    [Abstract] [Full Text] [Related]

  • 2. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW.
    Diabetologia; 1997 Oct 10; 40(10):1197-203. PubMed ID: 9349602
    [Abstract] [Full Text] [Related]

  • 3. Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes.
    Eriksson JW, Lönnroth P, Smith U.
    Diabetologia; 1992 Jun 10; 35(6):510-6. PubMed ID: 1319359
    [Abstract] [Full Text] [Related]

  • 4. The upregulating effect of insulin and vanadate on cell surface insulin receptors in rat adipocytes is modulated by glucose and energy availability.
    Yu ZW, Eriksson JW.
    Horm Metab Res; 2000 Aug 10; 32(8):310-5. PubMed ID: 10983626
    [Abstract] [Full Text] [Related]

  • 5. A stable peroxovanadium compound with insulin-like action in human fat cells.
    Eriksson JW, Lönnroth P, Posner BI, Shaver A, Wesslau C, Smith UP.
    Diabetologia; 1996 Feb 10; 39(2):235-42. PubMed ID: 8635677
    [Abstract] [Full Text] [Related]

  • 6. Vanadate augments insulin binding and prolongs insulin action in rat adipocytes.
    Fantus IG, Ahmad F, Deragon G.
    Endocrinology; 1990 Dec 10; 127(6):2716-25. PubMed ID: 2249624
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of 125I-transferrin binding and 59Fe uptake in rat adipocytes by vanadate: treatment time determines apparent tissue sensitivity.
    Tang S, Lu B, Fantus IG.
    Metabolism; 1998 Jun 10; 47(6):630-6. PubMed ID: 9627358
    [Abstract] [Full Text] [Related]

  • 8. Insulin can rapidly increase cell surface insulin binding capacity in rat adipocytes. A novel mechanism related to insulin sensitivity.
    Eriksson J, Lönnroth P, Smith U.
    Diabetes; 1992 Jun 10; 41(6):707-14. PubMed ID: 1316856
    [Abstract] [Full Text] [Related]

  • 9. Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes.
    Lönnroth P, Eriksson JW, Posner BI, Smith U.
    Diabetologia; 1993 Feb 10; 36(2):113-6. PubMed ID: 8458524
    [Abstract] [Full Text] [Related]

  • 10. The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level.
    Green A.
    Biochem J; 1986 Sep 15; 238(3):663-9. PubMed ID: 3541915
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect.
    Shisheva A, Shechter Y.
    Endocrinology; 1993 Oct 15; 133(4):1562-8. PubMed ID: 8404595
    [Abstract] [Full Text] [Related]

  • 12. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response.
    Fantus IG, Ahmad F, Deragon G.
    Diabetes; 1994 Mar 15; 43(3):375-83. PubMed ID: 7508873
    [Abstract] [Full Text] [Related]

  • 13. Insulin promotes and cyclic adenosine 3',5'-monophosphate impairs functional insertion of insulin receptors in the plasma membrane of rat adipocytes: evidence for opposing effects of tyrosine and serine/threonine phosphorylation.
    Eriksson JW, Lönnroth P, Wesslau C, Smith U.
    Endocrinology; 1997 Feb 15; 138(2):607-12. PubMed ID: 9002993
    [Abstract] [Full Text] [Related]

  • 14. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4).
    Lu B, Ennis D, Lai R, Bogdanovic E, Nikolov R, Salamon L, Fantus C, Le-Tien H, Fantus IG.
    J Biol Chem; 2001 Sep 21; 276(38):35589-98. PubMed ID: 11463798
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes.
    Castan I, Wijkander J, Manganiello V, Degerman E.
    Biochem J; 1999 Apr 15; 339 ( Pt 2)(Pt 2):281-9. PubMed ID: 10191258
    [Abstract] [Full Text] [Related]

  • 16. Cryptic receptors for insulin-like growth factor II in the plasma membrane of rat adipocytes--a possible link to cellular insulin resistance.
    Yu ZW, Wickman A, Eriksson JW.
    Biochim Biophys Acta; 1996 Jun 13; 1282(1):57-62. PubMed ID: 8679660
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of cell surface insulin receptors in primary cultured rat adipocytes by sodium vanadate.
    Marshall S, Monzon R.
    Endocrinology; 1987 Sep 13; 121(3):1116-22. PubMed ID: 3304977
    [Abstract] [Full Text] [Related]

  • 18. The insulin-mimetic agent vanadate promotes receptor endocytosis and inhibits intracellular ligand-receptor degradation by a mechanism distinct from the lysosomotropic agents.
    Fantus IG, George R, Tang S, Chong P, Poznansky MJ.
    Diabetes; 1996 Aug 13; 45(8):1084-93. PubMed ID: 8690156
    [Abstract] [Full Text] [Related]

  • 19. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
    Enrique-Tarancón G, Castan I, Morin N, Marti L, Abella A, Camps M, Casamitjana R, Palacín M, Testar X, Degerman E, Carpéné C, Zorzano A.
    Biochem J; 2000 Aug 15; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
    [Abstract] [Full Text] [Related]

  • 20. Vanadate enhances insulin-receptor binding in gestational diabetic human placenta.
    al-Attas OS, al-Dagheri NM, Vigo NT.
    Cell Biochem Funct; 1995 Mar 15; 13(1):9-14. PubMed ID: 7720193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.